Restless legs syndrome continues to puzzle, even with the recent publication of the first clinical guidelines for the disease.
A drug that reverses overdoses saves thousands of lives. Does its prescription status keep it from saving more?
New therapies for stroke, multiple sclerosis and other conditions may get a boost from interhospital cooperation.
One recent diagnostic advance may be guilty of stalling the fight against food-borne illness.
Two experts face off on new legislation that aims to speed up the approval process for drugs and medical devices.
Five state legislatures now allow terminal patients to circumvent the FDA. Will this new path to experimental drugs help or hurt?
After 50 years, we take a look back at the pharmaceutical industry’s first $100 million brand.
Although drug shortages have lessened in recent years, some key classes of medications remain in short supply.
Physicians routinely prescribe drugs for uses not approved by the FDA. But should drug reps be allowed to tout those uses?
May problems with therapies show up post-FDA approval. Could mining electronic data and online chatter head off trouble?
No Articles Found.